Yang et al. reported that cisplatin exerted antitumor roles in triple-Negative Breast Cancer through promoting MEG3/NLRP3/caspase-1/GSDMD pathway to mediate pyroptosis [23]. Here, MEG3 is linked to triple-negative breast carcinoma.